ID

44057

Beschreibung

Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01650129

Link

https://clinicaltrials.gov/show/NCT01650129

Stichworte

  1. 31.03.16 31.03.16 -
  2. 15.03.21 15.03.21 - Dr. rer. medic Philipp Neuhaus
  3. 20.09.21 20.09.21 -
Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT01650129

Eligibility Diabetes NCT01650129

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01650129
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with type 2 diabetes
Beschreibung

Type 2 diabetes

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
subjects with insulin treated for at least 24 weeks
Beschreibung

Duration of insulin treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0444921
UMLS CUI [1,2]
C0745343
hba1c maximum 11.0%
Beschreibung

Hba1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
body mass index (bmi) below 30.0 kg/m^2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
patients who have the skill of self-injection of insulin, and are able and willing to perform self-monitoring blood glucose (smbg) and are able to take measures against hypoglycaemic episodes
Beschreibung

Self-injection of insulin and self-monitoring blood glucose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3880392
UMLS CUI [1,2]
C0745343
UMLS CUI [2]
C0005803
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
recurrent severe hypoglycaemia
Beschreibung

Recurrent severe hypoglycaemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0342316
subjects with proliferative retinopathy or preproliferative retinopathy diagnosed within the last 12 weeks, or receiving photocoagulation therapy within the last one year
Beschreibung

Ophthalmological status

Datentyp

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2,1]
C0339473
UMLS CUI [2,2]
C2316983
UMLS CUI [3,1]
C0023694
UMLS CUI [3,2]
C2584899
impaired hepatic function
Beschreibung

Hepatic function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
impaired renal function
Beschreibung

Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
cardiac diseases
Beschreibung

Cardiac diseases

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
uncontrolled hypertension
Beschreibung

Uncontrolled hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C1868885
subjects with history of severe allergic or severe hypersensitive reactions
Beschreibung

Allergies and Hypersensitivity reactions

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
total daily insulin dose at least 100 iu
Beschreibung

Daily insulin dose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348070
UMLS CUI [1,2]
C0557978
treatment with oral hypoglycaemic agents within the last 4 weeks
Beschreibung

Oral hypoglycaemic agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C3173309

Ähnliche Modelle

Eligibility Diabetes NCT01650129

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01650129
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes
Item
subjects with type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Duration of insulin treatment
Item
subjects with insulin treated for at least 24 weeks
boolean
C0444921 (UMLS CUI [1,1])
C0745343 (UMLS CUI [1,2])
Hba1c
Item
hba1c maximum 11.0%
boolean
C0019018 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) below 30.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Self-injection of insulin and self-monitoring blood glucose
Item
patients who have the skill of self-injection of insulin, and are able and willing to perform self-monitoring blood glucose (smbg) and are able to take measures against hypoglycaemic episodes
boolean
C3880392 (UMLS CUI [1,1])
C0745343 (UMLS CUI [1,2])
C0005803 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Recurrent severe hypoglycaemia
Item
recurrent severe hypoglycaemia
boolean
C0342316 (UMLS CUI [1])
Ophthalmological status
Item
subjects with proliferative retinopathy or preproliferative retinopathy diagnosed within the last 12 weeks, or receiving photocoagulation therapy within the last one year
boolean
C0339467 (UMLS CUI [1])
C0339473 (UMLS CUI [2,1])
C2316983 (UMLS CUI [2,2])
C0023694 (UMLS CUI [3,1])
C2584899 (UMLS CUI [3,2])
Hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
Renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
Cardiac diseases
Item
cardiac diseases
boolean
C0018799 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Allergies and Hypersensitivity reactions
Item
subjects with history of severe allergic or severe hypersensitive reactions
boolean
C0020517 (UMLS CUI [1])
Daily insulin dose
Item
total daily insulin dose at least 100 iu
boolean
C2348070 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
Oral hypoglycaemic agents
Item
treatment with oral hypoglycaemic agents within the last 4 weeks
boolean
C0359086 (UMLS CUI [1,1])
C3173309 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video